A new study comparing the 2 weight-loss strategies found that people on an intermittent fasting plan were more successful.
A 4:3 nonconsecutive intermittent fasting regimen was more tolerable and yielded somewhat greater weight loss at 1 year than ...
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...
Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...
Sigrid Therapeutics, a Stockholm, Sweden, based non-pharmaceutical health tech company has secured approval for its weight loss food technology SiPore, Carb Fence in the US, with Europe approval in ...